HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES
The invention relates to novel organic compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.
-
Page/Page column 71-72
(2008/06/13)
SUBSTITUENT EFFECT ON THE SITE-SELECTIVE REACTION OF PYRIMIDINES